9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
Holders of 5% or more of NMTR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of 9 Meters Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of 9 Meters Biopharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on 9 Meters Biopharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2022 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Jun 28, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 13D/AOld format | – | – | – | SEC |
| Apr 7, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 13D/AOld format | – | – | – | SEC |
| Mar 25, 2021 | OrbiMed Israel BioFund GP Limited Partnership | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell 9 Meters Biopharma, Inc. shares.
No Form 144 notices for 9 Meters Biopharma, Inc. are on file.